January 16, 2024 03:16 PM EST
Pharma
FDA+

On­col­o­gy drugs lead 2023 new med­i­cines in Eu­rope — EMA re­port

Lia DeGroot

The Eu­ro­pean Med­i­cines Agency gave its stamp of ap­proval for 77 new drugs in 2023, with on­col­o­gy med­ica­tions lead­ing the pack with the most pos­i­tive …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ex­clu­sive: Flag­ship-backed Va­lo Health los­es in­ter­im CEO ahead of key Phase 2 read­out

Edge­wise’s stock surges as heart drug pass­es ear­ly safe­ty test

FDA in­spec­tors dis­cov­er trucks car­ry­ing torn-up records leav­ing In­di­an gener­ics fac­to­ry

Stem cell start­up spun out of George Church’s lab rais­es $75M

Lasker Award goes to three sci­en­tists who pi­o­neered re­search be­hind GLP-1 drugs

sponsored

Break­ing down si­los with a new quan­ti­ta­tive ap­proach to drug de­vel­op­ment

A service from the Financial Times